206 related articles for article (PubMed ID: 16570275)
1. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients.
Zhang YJ; Rossner P; Chen Y; Agrawal M; Wang Q; Wang L; Ahsan H; Yu MW; Lee PH; Santella RM
Int J Cancer; 2006 Sep; 119(5):985-91. PubMed ID: 16570275
[TBL] [Abstract][Full Text] [Related]
2. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
4. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
[TBL] [Abstract][Full Text] [Related]
6. RASSF1A hypermethylation is associated with aflatoxin B1 and polycyclic aromatic hydrocarbon exposure in hepatocellular carcinoma.
Feng Y; Xue WJ; Li P; Sha ZY; Huang H; Rui L; Li HX; Mao QS
Hepatogastroenterology; 2012 Sep; 59(118):1883-8. PubMed ID: 22172412
[TBL] [Abstract][Full Text] [Related]
7. Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Wang LW; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Cancer Lett; 2007 Jul; 252(1):104-14. PubMed ID: 17250958
[TBL] [Abstract][Full Text] [Related]
8. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls.
Chen SY; Wang LY; Lunn RM; Tsai WY; Lee PH; Lee CS; Ahsan H; Zhang YJ; Chen CJ; Santella RM
Int J Cancer; 2002 May; 99(1):14-21. PubMed ID: 11948486
[TBL] [Abstract][Full Text] [Related]
9. [The study on the interactions between polycyclic aromatic hydrocarbon-albumin adducts and various risk factors to primary hepatocellular carcinoma].
Zhao BH; Niu JJ; Guo F; Liu S; Pan LL
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 May; 44(5):427-32. PubMed ID: 20654233
[TBL] [Abstract][Full Text] [Related]
10. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Chen SY; Lee PH; Chen CJ; Santella RM
Cancer Lett; 2005 Apr; 221(2):135-43. PubMed ID: 15808399
[TBL] [Abstract][Full Text] [Related]
11. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
[TBL] [Abstract][Full Text] [Related]
12. Novel adenine adducts, N7-guanine-AFB1 adducts, and p53 mutations in patients with schistosomiasis and aflatoxin exposure.
Habib SL; Said B; Awad AT; Mostafa MH; Shank RC
Cancer Detect Prev; 2006; 30(6):491-8. PubMed ID: 17113242
[TBL] [Abstract][Full Text] [Related]
13. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
14. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
Chen CJ; Zhang YJ; Lu SN; Santella RM
Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
16. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
[TBL] [Abstract][Full Text] [Related]
17. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong IH; Lo YM; Zhang J; Liew CT; Ng MH; Wong N; Lai PB; Lau WY; Hjelm NM; Johnson PJ
Cancer Res; 1999 Jan; 59(1):71-3. PubMed ID: 9892188
[TBL] [Abstract][Full Text] [Related]
18. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
[TBL] [Abstract][Full Text] [Related]
19. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
Chen Ban K; Singh H; Krishnan R; Fong Seow H
J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
